Advertisements



Early Signs of Ovarian Cancer

Ovarian cancer is sometimes referred to as a silent killer because early symptoms are often absent or, when present, they are too vague. Even when there are signs, it’s common for primary care........»»

Category: blogSource: 247wallstJul 19th, 2019

A Big Step Forward in the Fight Against Ovarian Cancer

Aravive shares skyrocketed on Wednesday after the firm announced early-stage data for its ovarian cancer treatment......»»

Category: blogSource: 247wallstNov 20th, 2019

Subtle signs of ovarian cancer that might be easy to miss

David Litman/Shutterstock Symptoms of ovarian cancer might be missed by patients and doctors because they seem non-.....»»

Category: topSource: businessinsiderAug 31st, 2018

Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial

Merck KGaA and Pfizer Inc. said early Monday that the cancer immunotherapy avelumab did not meet the primary endpoints of a phase 3 ovarian cancer trial. The trial, JAVELIN Ovarian 200, teste.....»»

Category: topSource: marketwatchNov 19th, 2018

New Study Could Clear Johnson & Johnson on Talc, but Is It a Buy Signal?

A study published in JAMA found no conclusive link between powder usage and ovarian cancer riskRelated Stocks: JNJ,.....»»

Category: blogSource: gurufocusJan 13th, 2020

Column: Study finds no link between talc and ovarian cancer, but don"t expect the lawsuits to stop

A new study says talc doesn't cause ovarian cancer A new study says talc doesn't cause ovarian cancer.....»»

Category: topSource: latimesJan 7th, 2020

Largest talc study gives no clear link to ovarian cancer

Overall, the study did not find a significantly increased risk of ovarian cancer.....»»

Category: topSource: foxnewsJan 7th, 2020

Study questions talc link to ovarian cancer, Bloomberg reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2020

Talc link to ovarian cancer questioned in JAMA published study, Bloomberg says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2020

How to check for skin cancer using your smartphone

Skin cancer is the most common type of disease in the U.S., as per the American Academy of Dermatology. However, like with every disease, early... The post How to check for skin cancer using your smartphone appeared first on ValueWalk......»»

Category: blogSource: valuewalkJan 6th, 2020

Oil starts 2020 steady as trade optimism, Mideast tensions support

Oil prices steadied after early gains on Thursday as signs of improving trade relations between the United States and China which eased demand concerns and rising tensions in the Middle East provided support......»»

Category: topSource: reutersJan 2nd, 2020

Why This Ovarian Cancer Drug Could Be Huge for NewLink Genetics

NewLink Genetics shares jumped on Tuesday after the company announced that it entered into an exclusive worldwide license agreement with Ellipses Pharma......»»

Category: blogSource: 247wallstDec 24th, 2019

Phoenix biotech company raises $36.6M for early lung cancer detection

VisionGate is a clinical stage oncology pharmaceutical and diagnostics company focused on the early detection and prevention of cancer......»»

Category: topSource: bizjournalsDec 23rd, 2019

Seattle Genetics Drug For Difficult-To-Treat Urothelial Cancer Gets Early FDA Nod

Seattle Genetics, Inc. (NASDAQ: SGEN) shares are advancing following an early approval for Padcev, an antibody conjugate therapy it is co-developing with Astellas Pharma Inc. (OTC: ALPMY). Latest Ratings for SGEN DateFirmAct.....»»

Category: blogSource: benzingaDec 19th, 2019

ImmunoGen shares rise on ovarian cancer study

Shares of ImmunoGen Inc. gained 18% in afternoon trading after the biotechnology company announced that the Food and Drug Administration had cleared a trial for its investigational ovarian cancer drug to be used to supp.....»»

Category: topSource: marketwatchDec 17th, 2019

Why Accelerated Approval Could Be Huge for This Ovarian Cancer Study

ImmunoGen shares jumped on Tuesday after the FDA advised that a new single-arm study in platinum-resistant ovarian cancer could support accelerated approval......»»

Category: blogSource: 247wallstDec 17th, 2019

Why These Breast Cancer Study Results Look So Promising

Puma Biotechnology shares made a handy gain early on Thursday after the company presented updated results from its Phase 2 Summit clinical trial of neratinib at the 2019 San Antonio Breast Cancer........»»

Category: blogSource: 247wallstDec 12th, 2019

Fate Therapeutics" stock rises on early-stage cancer drug data

Shares of Fate Therapeutics gained 37% after it shared promising data from one clinical and one preclinical study for its experimental cancer immunotherapy treatments. The company is testing two therapies, FT516 and FT500, in.....»»

Category: topSource: marketwatchDec 9th, 2019

Weeks after IPO, Peninsula drug maker lines up Asian cancer-fighting deal

The South San Francisco company's drug, currently in an early-phase clinical trial, targets types of breast and lung cancers as well as gastric cancer, which Asian drug makers are anxious to tackle......»»

Category: topSource: bizjournalsDec 4th, 2019

Every reason to check your credit report before the end of the year, even if your credit is excellent

Westend61/Getty Images Checking over your credit reports each year is the best way to find reporting errors and early signs of identity theft.....»»

Category: topSource: businessinsiderNov 25th, 2019

‘I wish I had known sooner’: Alex Trebek wants you to learn the signs of pancreatic cancer

Thursday is World Pancreatic Cancer Day. The overall five-year survival rate for pancreatic cancer is 9%......»»

Category: topSource: marketwatchNov 21st, 2019